Phase 3Completed

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

A Multicenter, Randomized, Double-Blind, Parallel, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hypercholesterolemia at High or Moderately High Risk for Coronary Heart Disease

Sponsor
Organon and Co (Industry)
Enrollment
1,289 enrolled
Conditions
Hypercholesterolemia
Interventions
Atorvastatin 10 mg; Ezetimibe 10 mg/simvastatin 20 mg; Atorvastatin 20 mg; Ezetimibe 10 mg/simvastatin 40 mg; Atorvastatin 40 mg
Ages
older adults
Registry
NCT00535405

Full record on ClinicalTrials.gov

From the registry

A multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus atorvastatin in elderly patients with high cholesterol at high or moderately high risk for coronary heart disease.

Primary outcomes

  • Percent Change From Baseline in Low Density Lipoprotein (LDL-C) at Week 12

History

  1. Last registry update

  2. Results first posted

  3. Primary completion

  4. Started

  5. Registered